IP Library Granted Patent US 11,020,570
Granted Patent B2
US 11,020,570 · App. 16/502,766 · Granted Jun 1, 2021

Methods and devices for treatment of stenosis of arteriovenous fistula shunts

Inventors: James B. Laudenslager (San Marcos, CA); Dean S. Irwin (Carlsbad, CA)
Assignee: RA MEDICAL SYSTEMS, INC.
A61M25/09A61B18/245A61B50/30A61B2018/0041A61B2018/00285A61B2018/00577A61B2018/206A61B2018/2222A61B2018/2238A61B2050/314A61B2090/3966A61M25/002A61M2025/0177A61M2025/105
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,020,570
App. No.
16/502,766
Granted
Jun 1, 2021
Kind
B2
Abstract

Devices and methods are discussed directed to the use of a low profile laser ablation catheter for use in laser ablation removal of arterial plaque blockages to restore blood flow in the treatment of arteriovenous fistulas. Also discussed are devices and methods directed to packaging, long term storage and sterilization of liquid core ablation catheters.

Claims (18)

1. A method of treating a blockage in a vessel of a patient, comprising:

emitting pulsed ultraviolet laser ablation energy from a XeCl excimer laser at a nominal output wavelength of about 308 nm and a repetition rate of less than about 100 Hz into an input end of an ablation catheter;

transmitting the pulsed ultraviolet laser ablation energy through the ablation catheter to an active emitting surface comprising at least about 50 percent of an area of a distal end of the ablation catheter; and

axially advancing and guiding a distal end of the ablation catheter through the blockage while emitting the pulsed ultraviolet laser ablation energy from the active emitting surface of the distal end of the ablation catheter while ablating and debulking the blockage by photodissociation thereof.

2. The method of claim 1 wherein the ablation catheter further comprises a radiopaque marker band disposed on the distal end of the ablation catheter and further comprising imaging the distal end of the ablation catheter using fluoroscopy.

3. The method of claim 1 further comprising emitting red light from a red diode laser and the distal end of the ablation catheter and visualizing a position of the distal end of the ablation catheter using diffusion of the red light through skin of the patient.

4. The method of claim 1 wherein guiding the distal end of the ablation catheter comprises advancing the distal end of the ablation catheter from a distal end of a support catheter comprising a deflectable distal section.

5. The method of claim 1 wherein axially advancing and guiding the distal end of the ablation catheter comprises axially advancing and guiding the ablation catheter which comprises a liquid filled ultraviolet light transmitting ablation catheter including a biocompatible liquid core, the liquid core being sealed at both ends with ultraviolet light transmitting windows.

6. The method of claim 1 guiding the distal end of the ablation catheter comprises advancing the ablation catheter over a guidewire.

7. The method of claim 1 wherein guiding the distal end of the ablation catheter comprises advancing the distal end of the ablation catheter from a distal end of a support catheter.

8. The method of claim 7 wherein advancing the distal end of the ablation catheter from the distal end of the support catheter comprises advancing the distal end of the ablation catheter up to about 5 mm from the distal end of the support catheter.

9. The method of claim 7 further comprising axially advancing the support catheter relative to the ablation catheter while holding the ablation catheter stationary, and then repeating this process at least one additional time.

10. The method of claim 7 further comprising ablating a lumen through the blockage that is greater in transverse dimension than a transverse dimension of the ablation catheter by transversely re-positioning the distal end of the ablation catheter and then axially advancing the ablation catheter through the blockage again with distal end of the ablation catheter transversely re-positioned while emitting pulsed ultraviolet laser ablation energy from the distal end of the ablation catheter and further ablating additional material of the blockage.

11. The method of claim 10 wherein the distal end of the support catheter comprises an angled distal section and transversely re-positioning the distal end of the support catheter comprises nutating the angled distal section of the support catheter.

12. The method of claim 10 wherein the distal end of the support catheter comprises a deflectable distal section and transversely re-positioning the distal end of the support catheter comprises deflecting the deflectable distal section of the support catheter.

13. The method of claim 10 wherein re-positioning the distal end of the ablation catheter comprises inserting a guidewire in a channel newly formed by the ablation catheter and then advancing the ablation catheter through the newly formed channel adjacent the guidewire.

14. The method of claim 13 wherein re-positioning the distal end of the ablation catheter comprises inserting a plurality of guidewires into the channel newly formed by the ablation catheter and then advancing the ablation catheter through the newly formed channel adjacent the plurality of guidewires.

15. The method of claim 1 wherein the ablation catheter comprises an eccentric guidewire lumen with a distal end of the eccentric guidewire lumen being disposed adjacent the distal end of the liquid core ablation catheter and having an axial length of at least about 10 cm and wherein axially advancing and guiding the ablation catheter further comprises axially advancing the ablation catheter over a guidewire disposed within the eccentric guidewire lumen.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 22, 2019
From: LAUDENSLAGER, JAMES B.; IRWIN, DEAN S.
To: RA MEDICAL SYSTEMS, INC.
Reel/Frame 050138/0794 →
Continuity (4)
Continuation 15723062 · Oct 2, 2017
Division 14515435 · Oct 15, 2014
Provisional Application 61891830 · Oct 16, 2013
Related Publication 20190336732A1 · Nov 7, 2019